123 results
8-K
EX-1.1
VBIVQ
VBI Vaccines Inc
15 May 24
VBI Vaccines Reports First Quarter 2024 Financial Results
4:18pm
satisfaction of the additional conditions specified in Section 6 of this Agreement.
(ix) If the Company shall declare or make any dividend or other
8-K
EX-10.1
1n7 ct4gto
11 Apr 24
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:07pm
8-K
EX-4.2
lnvzy0c
11 Apr 24
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:07pm
8-K
EX-99.1
dvxivg85qu vqhx6ayml
11 Apr 24
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:07pm
8-K
EX-5.2
wlz691t7ez22vf
11 Apr 24
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:07pm
8-K
EX-4.1
jw8xf qcyq8c22
11 Apr 24
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:07pm
424B5
fgmjdky3rla
11 Apr 24
Prospectus supplement for primary offering
9:06am
8-K
EX-5.3
61rx5q9r lll5sp
11 Jul 23
Other Events
4:05pm
8-K
EX-5.4
i3biejgi
11 Jul 23
Other Events
4:05pm
424B5
qwf675mjyn32jw
7 Jul 23
Prospectus supplement for primary offering
5:25pm
8-K
EX-99.1
0419yn fsng
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm